908 Devices Inc. (MASS): Price and Financial Metrics

908 Devices Inc. (MASS): $6.95

0.34 (+5.14%)

POWR Rating

Component Grades














  • Value is the dimension where MASS ranks best; there it ranks ahead of 56.28% of US stocks.
  • MASS's strongest trending metric is Growth; it's been moving down over the last 178 days.
  • MASS ranks lowest in Growth; there it ranks in the 9th percentile.

MASS Stock Summary

  • 908 DEVICES INC's stock had its IPO on December 18, 2020, making it an older stock than only 9.7% of US equities in our set.
  • MASS's equity multiplier -- a measure of assets relative to shareholders'equity -- is greater than that of just 15.42% of US stocks.
  • In terms of volatility of its share price, MASS is more volatile than 89.2% of stocks we're observing.
  • Stocks that are quantitatively similar to MASS, based on their financial statements, market capitalization, and price volatility, are BASE, SOPH, SSYS, DLB, and TMDX.
  • MASS's SEC filings can be seen here. And to visit 908 DEVICES INC's official web site, go to www.908devices.com.

MASS Valuation Summary

  • In comparison to the median Healthcare stock, MASS's EV/EBIT ratio is 133.59% lower, now standing at -2.2.
  • Over the past 27 months, MASS's EV/EBIT ratio has gone up 605.6.

Below are key valuation metrics over time for MASS.

Stock Date P/S P/B P/E EV/EBIT
MASS 2023-03-17 5.1 1.3 -7.2 -2.2
MASS 2023-03-16 5.9 1.5 -8.2 -3.2
MASS 2023-03-15 6.1 1.5 -8.5 -3.5
MASS 2023-03-14 5.1 1.3 -9.6 -3.2
MASS 2023-03-13 4.9 1.3 -9.2 -2.8
MASS 2023-03-10 5.0 1.3 -9.3 -3.0

MASS's Quality Factors

The “Quality” component of the POWR Ratings focuses on 31 different factors of a companies fundamentals and operational strength. Here are some key insights as we drill into the specifics of these quality attributes.
  • MASS has a Quality Grade of C, ranking ahead of 42% of graded US stocks.
  • MASS's asset turnover comes in at 0.188 -- ranking 66th of 75 Measuring and Control Equipment stocks.
  • 500 - Internal server error

The table below shows MASS's key quality metrics over time.

Period Asset Turnover Gross Margin ROIC
2021-09-30 0.188 0.52 -0.825

MASS Price Target

For more insight on analysts targets of MASS, see our MASS price target page. And for a list of of all stocks sorted by upside potential based on analyst target price, see our Top Price Target page.

Average Price Target $55.00 Average Broker Recommendation 1.12 (Strong Buy)

MASS Stock Price Chart Interactive Chart >

Price chart for MASS

MASS Price/Volume Stats

Current price $6.95 52-week high $26.00
Prev. close $6.61 52-week low $6.38
Day low $6.66 Volume 912,276
Day high $7.10 Avg. volume 298,048
50-day MA $9.19 Dividend yield N/A
200-day MA $14.01 Market Cap 222.73M

908 Devices Inc. (MASS) Company Bio

908 Devices, Inc. develops measurement devices for chemical and biochemical analysis. It develops its products using mass spectrometry technology, an analytical technique for measuring the mass of charged molecules that is used in chemical analysis laboratories for applications, such as safety and security, food science, biotechnology, clinical diagnostics, and controlling industrial processes. Its products include desktops and handhelds. The company was founded by Kevin J. Knopp, Miller Scott, Steve Araiza, Andrew Bartfay, Michael Jobin, Christopher D. Brown, and Christopher J. Petty in 2012 and is headquartered in Boston, MA.

MASS Latest News Stream

Event/Time News Detail
Loading, please wait...

MASS Latest Social Stream

Loading social stream, please wait...

View Full MASS Social Stream

Latest MASS News From Around the Web

Below are the latest news stories about 908 DEVICES INC that investors may wish to consider to help them evaluate MASS as an investment opportunity.

Q4 2022 908 Devices Inc. Earnings Call

Q4 2022 908 Devices Inc. Earnings Call

Yahoo | March 8, 2023

908 Devices Inc. (MASS) Reports Q4 Loss, Tops Revenue Estimates

908 Devices Inc. (MASS) delivered earnings and revenue surprises of -40.91% and 1.77%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?

Yahoo | March 7, 2023

908 Devices Reports Fourth Quarter and Full Year 2022 Financial Results and Provides 2023 Revenue Outlook

BOSTON, March 07, 2023--908 Devices Inc. (Nasdaq: MASS), a pioneer of purpose-built handheld and desktop devices for chemical and biochemical analysis, today reported financial results for the quarter and full year ended December 31, 2022.

Yahoo | March 7, 2023

ViewRay (VRAY) Reports Q4 Loss, Misses Revenue Estimates

ViewRay (VRAY) delivered earnings and revenue surprises of 6.25% and 0.71%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?

Yahoo | February 27, 2023

908 Devices to Participate in the Cowen 43rd Annual Healthcare Conference

BOSTON, February 21, 2023--908 Devices Inc., (Nasdaq: MASS) a pioneer of handheld and desktop devices for chemical and biochemical analysis, today announced it will participate in the upcoming Cowen 43rd Annual Healthcare Conference in Boston, MA.

Yahoo | February 21, 2023

Read More 'MASS' Stories Here

MASS Price Returns

1-mo -34.12%
3-mo -17.26%
6-mo -55.82%
1-year -62.08%
3-year N/A
5-year N/A
YTD -8.79%
2022 -70.55%
2021 -54.57%
2020 N/A
2019 N/A
2018 N/A

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!

Page generated in 1.5157 seconds.